PRESS RELEASE published on 04/17/2023 at 12:45, 3 years 3 months ago NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
PRESS RELEASE published on 04/04/2023 at 13:45, 3 years 3 months ago NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates
PRESS RELEASE published on 02/15/2023 at 12:30, 3 years 5 months ago NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials
PRESS RELEASE published on 01/04/2023 at 12:35, 3 years 6 months ago NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Published on 07/31/2026 at 08:00, 3 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 07/31/2026 at 01:39, 6 hours 24 minutes ago Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 8 hours 18 minutes ago Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 9 hours 2 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 9 hours 3 minutes ago Eagle Plains Announces Approval of Warrant Expiry Extension
Published on 07/31/2026 at 07:30, 33 minutes ago SURTECO GROUP SE: Sales and earnings within the target corridor; rise in adjusted and reported EBITDA; forecast confirmed
Published on 07/31/2026 at 07:30, 33 minutes ago R. STAHL publishes half-year results – Sales and profitability in line with planning – Forecast for 2026 confirmed
Published on 07/31/2026 at 07:29, 34 minutes ago RBI: Semi-Annual Financial Report 2026 - Consolidated profit (excl. Russia) up 25%
Published on 07/31/2026 at 07:25, 38 minutes ago EQS-Adhoc: UBS AG: UBS AG published its 2Q26 financial report
Published on 07/31/2026 at 07:00, 1 hour 3 minutes ago Medacta Group SA: Medacta reports continued above-market revenue growth of 9.7% in c.c. in H1 2026
Published on 07/30/2026 at 18:15, 13 hours 48 minutes ago Publication of the 2026 half-year financial report
Published on 07/30/2026 at 18:00, 14 hours 3 minutes ago PR ICADE – ACQUISITION OF A CONTROLLING INTEREST IN COMET
